Abstract:Background: Cancer as the most malignant disease still demands the more effective therapeutics methods although continuous efforts have been input to cancer therapies. Recent studies indicate that only a small subset of cancer cells termed cancer stem cells (CSCs) contributes to tumor progression, metastasis and drug-resistance. Drugs targeting to CSCs might become more effective approaches to cancer therapy. To date, isolation and characterization of CSCs have largely depended on surface markers which are not specific or well-recognized for individual tumor types. Our goal is to develop methods for isolating and characterizing a set of lung CSCs based on the specific binding peptides for CSCs without any recognized definitive specific surface markers. Materials and Methods: Stem-like cells were enriched from non-small cell lung cancer (NSCLC) cell line H460 by sphere-forming assay. Characterized these stem-like cells by colony-forming assay, drug-resistance assay and soft agar assay. Screening and identification of specific binding peptides for CSCs were performed with bacteria surface display methods. The affinity between the specific binding peptides and CSCs was determined with fluorescence microscope and flow cytometric analysis. The specificity of peptides binding with CSCs was examined through comparing the binding capacity of peptides with either H460 cells or other cell lines including stem cells. The isolation of CSCs was performed using specific fluorescent peptides with FACS machine. The further characterization of selected CSCs including exploring the source and tumorigenesis mechanism of CSCs was performed through miRNA analysis. Results: Stem-like cells divided and formed tumor spheres in a couple of weeks, while most of cancer cells died in the serum-free medium. These stem-like cells were able to grow indefinitely as tumor spheres in long-term culture (more than 20 passages). Meanwhile, sphere cells could form colonies in the soft agar plates and exhibit the drug resistance capacity, which indicated that these sphere cells behaved as CSCs. Three peptides binding specifically to those CSCs were identified with bacteria surface display method. They could seldom bind with other cell types including H460 cells, H1299 sphere cells, HLF cells, MSCs and ESCs. One selected peptides named HCBP-1 exhibited highly specific binding capacity to H460 CSCs. The apparent dissociation constant (KD) was 6.4 × 10-7 M with a flow cytometry-based assay. In the peptides binding subgroup of H460 cells, at least 10 miRNAs presented the different expression rate from the H460 cells. Conclusions: In our study, a panel of specific binding peptides was identified with bacteria surface display method which could be used for isolation and characterization of CSCs without definitive CSCs markers. Furthermore, this new method could be potentially expanded to characterize and isolate CSCs in any types of cancer. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):A54. Citation Format: Yimin Zhu, Anxin Wang. Isolation and characterization of cancer stem cells with peptides. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr A54.

Ribosome Display and Selection of Single‐chain Variable Fragments Effectively Inhibit Growth and Progression of Microspheres in Vitro and in Vivo

Molecular Imaging in Tracking Tumor Stem-Like Cells

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

A high-throughput screen identifies inhibitors of lung cancer stem cells

Abstract A54: Isolation and Characterization of Cancer Stem Cells with Peptides.

Microfluidic Tandem Mechanical Sorting System for Enhanced Cancer Stem Cell Isolation and Ingredient Screening

Identification of stem-like cells in non-small cell lung cancer cells with specific peptides.

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Plasma Membrane Proteomics of Tumor Spheres Identify CD166 As a Novel Marker for Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma*

MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

Role of microRNAs in the Regulation of Breast Cancer Stem Cells

Promoting Tumor Penetration of Nanoparticles for Cancer Stem Cell Therapy by TGF-β Signaling Pathway Inhibition

Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance

Using microfluidic and conventional platforms to evaluate the effects of lanthanides on spheroid formation

Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays

Microdevices for cancer stem cell culture as a predictive chemotherapeutic response platform

A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.

An Alginate-Based Platform for Cancer Stem Cell Research

Suppress Orthotopic Colon Cancer and Its Metastasis Through Exact Targeting and Highly Selective Drug Release by a Smart Nanomicelle.

Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.